Lys Therapeutics
PrivateLast Round
Financing
Jun 22, 2026
Momentum
Top 5%
of companies Caplight tracks
Company Overview
-
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Keywords
monoclonal antibodyblood-brain barrier therapyBBB therapymAb therapyfirst-in-class drugneuroinflammation therapyneurodegenerative diseaseneurovascular diseasetherapeutic antibodypreclinical biotechdrug licensingmultiple sclerosisParkinson's diseaseischemic strokedrug discoverytissue plasminogen activatortPA
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Lys Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Lys Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Financing | Jun 22, 2026 |
Lys Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Financing |
| Bpifrance | Financing |
| The Michael J. Fox Foundation for Parkinson's Research | Financing |
| Normandie Participations | Financing |
| Bpifrance | Financing |
| Zcube | Financing |
| TCD Capital | Financing |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
$29M raised with participation from Bpifrance and France 2030.
Lys Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Lys Therapeutics's valuation, stock price, and market status.